Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: A 48-week randomized clinical trial

Research output: Contribution to journalArticle

Original languageEnglish (US)
Number of pages1
JournalInfectious Diseases in Clinical Practice
Volume12
Issue number4
DOIs
Publication statusPublished - Jan 1 2004

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this